When I wake up some mornings, I check on my mum to see how she’s faring. Then I mentally review two different calendars. One of…
Myeloma
Gilead said it has completed its $7.8 billion acquisition of Arcellx, a deal the company hopes will allow it to streamline and accelerate the…
Note: This column describes the author’s experience with Revlimid (lenalidomide). Not everyone will have the same response to treatment. Consult your doctor before starting or…
Some days when I’m caregiving for my mum, I’ve noticed that the hardest part isn’t what one might expect. The hardest part doesn’t have anything…
The Center for Cancer and Blood Disorders (CCBD), a network of community-based oncology practices across Maryland, has launched a program to make CAR…
Have you seen “The Pitt?” The medical drama on HBO Max is not for the faint of heart as it races from case…
It started with bruises on my mum’s arms. They were small, purple, and red, as if she had fallen down. While we were still trying…
The U.S. Food and Drug Administration (FDA) has granted fast track status to Opna Bio‘s OPN-6602 as a potential treatment for people…
Note: This column describes the author’s experience with several multiple myeloma treatments. Not everyone will have the same response to treatment. Consult your doctor before…
Her name badge looked so common and ordinary; it was a tiny, plastic square attached to the hem of a pocket on her scrubs. But…
Recent Posts
- New AI tool can help doctors better detect early pancreatic cancer
- The parallel calendars: Living between treatment cycles and ordinary days
- First participant receives GLIX1 in early glioblastoma clinical trial
- World Ovarian Cancer Day campaign spotlights scars seen and unseen
- Gilead completes Arcellx buy, securing myeloma treatment anito-cel
